| scholarly article | Q13442814 |
| P2093 | author name string | L Lu | |
| D T Boumpas | |||
| A Kaliyaperumal | |||
| S K Datta | |||
| P2860 | cites work | Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen | Q27748865 |
| Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor | Q33787097 | ||
| Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus | Q34199681 | ||
| Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo | Q34228758 | ||
| The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus | Q34234795 | ||
| Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein | Q34293468 | ||
| Cytokine abnormalities in human lupus | Q36140616 | ||
| Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes | Q36302196 | ||
| Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus | Q36361685 | ||
| Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles | Q36361966 | ||
| Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes | Q36363024 | ||
| Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus | Q36364479 | ||
| Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus | Q36366783 | ||
| Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease | Q36377160 | ||
| Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor alpha chain | Q36400210 | ||
| Systemic exposure to irradiated apoptotic cells induces autoantibody production | Q36401434 | ||
| Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production | Q37354525 | ||
| Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice | Q37356556 | ||
| Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency | Q37365738 | ||
| Roles of interferon-gamma and interleukin-4 in murine lupus | Q37365961 | ||
| Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice | Q37377479 | ||
| Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus | Q37388021 | ||
| Junctional region sequences of T-cell receptor beta-chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T cells from lupus mice: possible selection by cationic autoantigens | Q37644134 | ||
| Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease | Q37708458 | ||
| Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size | Q39229154 | ||
| Several common HLA-DR types share largely overlapping peptide binding repertoires | Q41052906 | ||
| Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands | Q41342616 | ||
| Self antigens and epitope spreading in systemic autoimmunity | Q41564944 | ||
| Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations | Q41840721 | ||
| Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation | Q42060819 | ||
| Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice | Q42942093 | ||
| T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis | Q44381577 | ||
| Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity | Q46792549 | ||
| Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. | Q52054451 | ||
| Flow-Cytometric Assessment ofin VivoCytokine-Producing Monocytes in HIV-Infected Patients | Q57723266 | ||
| Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus | Q57740770 | ||
| A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire | Q63535316 | ||
| Dual reactivity of several monoclonal anti-nucleosome autoantibodies for double-stranded DNA and a short segment of histone H3 | Q64389360 | ||
| The NZB X SWR model of lupus nephritis. II. Autoantibodies deposited in renal lesions show a distinctive and restricted idiotypic diversity | Q68809502 | ||
| CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis | Q70049950 | ||
| Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus | Q71781135 | ||
| Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex | Q72575081 | ||
| Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice | Q73026032 | ||
| Mapping of linear histone regions exposed at the surface of the nucleosome in solution | Q73876602 | ||
| Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production | Q73994619 | ||
| Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology | Q74477147 | ||
| Genetic susceptibility to systemic lupus erythematosus | Q74578130 | ||
| A very high level of crossreactivity is an essential feature of the T-cell receptor | Q77324273 | ||
| Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells | Q77404750 | ||
| Susceptibility to lupus nephritis in the NZB/W model system | Q77892082 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 345-355 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Major peptide autoepitopes for nucleosome-specific T cells of human lupus. | |
| P478 | volume | 104 |
| Q40834819 | Activation of autoreactive T cells that help nucleobindin-injected mice produce anti-DNA antibodies |
| Q64102174 | Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target |
| Q82042052 | Analysis of the interindividual conservation of T cell receptor alpha- and beta-chain variable regions gene in the peripheral blood of patients with systemic lupus erythematosus |
| Q24804980 | Antigen-specific cytometry |
| Q37207000 | Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells |
| Q83116640 | Autoantibodies in systemic lupus erythematosus |
| Q46316594 | Autoantigen microarrays for multiplex characterization of autoantibody responses |
| Q36527598 | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus |
| Q44534952 | B Cells Are Indispensable for a Novel Mouse Model of Primary Sjögren's Syndrome |
| Q52932212 | CD4 positive peripheral T cells from patients with systemic lupus erythematosus (SLE) are clonally expanded. |
| Q87440682 | CD4+ Th1 cells are effectors in lupus nephritis--but what are their targets? |
| Q49213049 | Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB x NZW F1 mice. |
| Q97883531 | Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis |
| Q36993221 | Developments in the scientific understanding of lupus |
| Q39303557 | Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus. |
| Q37575071 | Epigenetic histone code and autoimmunity |
| Q34736496 | Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences |
| Q42101525 | Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis |
| Q51840990 | High alpha-defensin levels in patients with systemic lupus erythematosus. |
| Q48022316 | Human lupus T cells resist inactivation and escape death by upregulating COX-2. |
| Q33674468 | Identification of autoreactive B cells with labeled nucleosomes |
| Q37929621 | Immune mechanisms underlying the beneficial effects of autologous hematopoietic stem cell transplantation in multiple sclerosis |
| Q40961898 | Immunomodulation of RA Patients' PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens. |
| Q37150868 | Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus |
| Q33765614 | Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy. |
| Q37052040 | Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice |
| Q40514474 | Innate and humoral recognition of the products of cell death: differential antigenicity and immunogenicity in lupus |
| Q37212277 | LMW heparin prevents increased kidney expression of proinflammatory mediators in (NZBxNZW)F1 mice |
| Q73081459 | Laboratory protocols for the identification of Th cell epitopes on self-antigens in mice with systemic autoimmune diseases |
| Q37644507 | Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease |
| Q35119907 | Major Peptide Autoepitopes for Nucleosome‐Centered T and B Cell Interaction in Human and Murine Lupus |
| Q37361089 | Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity |
| Q73740126 | Major peptide autoepitopes for nucleosome-specific T cells of human lupus |
| Q47702702 | Mechanisms of anti-DNA antibody production |
| Q36016443 | Megakaryocyte progenitors are the main APCs inducing Th17 response to lupus autoantigens and foreign antigens |
| Q81342162 | Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis |
| Q35090145 | Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases |
| Q41933746 | Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus |
| Q91652147 | Peptide-Based Vaccination Therapy for Rheumatic Diseases |
| Q35661224 | Peptide-based immunotherapy of systemic lupus erythematosus |
| Q46532671 | Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration |
| Q37444305 | Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus |
| Q36419022 | Regulatory T cells in lupus |
| Q37855952 | Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity |
| Q41810518 | S antigen specific effector T cell activation detected by cytokine flow cytometry. |
| Q36254076 | SLE: translating lessons from model systems to human disease |
| Q36577432 | Systemic lupus erythematosus--2005 annus mirabilis? |
| Q43050965 | T cell reactivity against the SmD1(83-119) C terminal peptide in patients with systemic lupus erythematosus |
| Q36626989 | T cells, murine chronic graft-versus-host disease and autoimmunity |
| Q35998853 | T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens |
| Q37800308 | The future of lupus therapy modulating autoantigen recognition |
| Q35074594 | The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms |
| Q36856706 | The interferon-α signature of systemic lupus erythematosus |
| Q33716669 | The role of B cells in lupus pathogenesis |
| Q37737799 | The role of dendritic cells in the pathogenesis of systemic lupus erythematosus |
| Q34731092 | Therapy of systemic lupus erythematosus: a look into the future |
| Q43049852 | Toll-like receptors and innate immune responses in systemic lupus erythematosus. |
| Q35045914 | Triggers for anti-chromatin autoantibody production in SLE. |
Search more.